Glass particles found in generic atorvastatinBMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e8236 (Published 03 December 2012) Cite this as: BMJ 2012;345:e8236
- Edward Davies
- 1New York
Ranbaxy Pharmaceuticals has stopped production and issued a recall of its generic version of the cholesterol lowering drug atorvastatin.
The recall applies to certain lots of the company’s 10 mg, 20 mg, and 40 mg tablets. The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, are being …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial